• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,323
3,587
3,475
2,880
2,813

COUNTRY

2,408
900
279
269
227

CATEGORIES

  • 940
  • 179
    • 43
    • 213
    • 50
  • 173
  • 295
    • 51
  • 506
  • 233
  • 242
  • 60
  • 64
  • 868
  • 1,522
  • 823
  • 20
  • 499
  • 1,431
  • 2,411
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 270
  • 32
  • 2,637
SHOW ALL…

PRICE

2,740
7,610
16,995
30,304

PUBLISHED

2,171
3,772
12,610
30,304

PRODUCT TYPE

27,341
1,090
1,038
524
163
58
23
21
20
16
6
3
1

Pharmaceuticals

(30,304 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Platelet Receptor Inhibitors -Pipeline Insights Platelet Receptor Inhibitors -Pipeline Insights - Product Thumbnail Image

Platelet Receptor Inhibitors -Pipeline Insights

“Platelet Receptor Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the...

February 2015
FROM
mRNA Guanylyltransferase Inhibitors -Pipeline Insights mRNA Guanylyltransferase Inhibitors -Pipeline Insights - Product Thumbnail Image

mRNA Guanylyltransferase Inhibitors -Pipeline Insights

“mRNA Guanylyltransferase Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Motilin Receptor Agonists -Pipeline Insights Motilin Receptor Agonists -Pipeline Insights - Product Thumbnail Image

Motilin Receptor Agonists -Pipeline Insights

“Motilin Receptor Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Endothelin Receptor (ET) Antagonists -Pipeline Insights Endothelin Receptor (ET) Antagonists -Pipeline Insights - Product Thumbnail Image

Endothelin Receptor (ET) Antagonists -Pipeline Insights

“Endothelin Receptor (ET) Antagonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights - Product Thumbnail Image

Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights

“Endothelin Converting Enzyme (ECE) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is...

February 2015
FROM
Carbonic Anhydrase 2 (CA2) Inhibitors -Pipeline Insights Carbonic Anhydrase 2 (CA2) Inhibitors -Pipeline Insights - Product Thumbnail Image

Carbonic Anhydrase 2 (CA2) Inhibitors -Pipeline Insights

“Carbonic Anhydrase 2 (CA2) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Anti-CD274 (PD-L1) Antibody -Pipeline Insights Anti-CD274 (PD-L1) Antibody -Pipeline Insights - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody -Pipeline Insights

“Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Neutral Endopeptidase Inhibitors (NEP Inhibitors) -Pipeline Insights Neutral Endopeptidase Inhibitors (NEP Inhibitors) -Pipeline Insights - Product Thumbnail Image

Neutral Endopeptidase Inhibitors (NEP Inhibitors) -Pipeline Insights

“Neutral Endopeptidase Inhibitors (NEP Inhibitors)-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report...

February 2015
FROM
Neurotrophin Enhancers -Pipeline Insights Neurotrophin Enhancers -Pipeline Insights - Product Thumbnail Image

Neurotrophin Enhancers -Pipeline Insights

“Neurotrophin Enhancers-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights - Product Thumbnail Image

Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights

“Janus Kinase 1 (JAK1) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights - Product Thumbnail Image

Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights

“Janus Kinase (JNK) Pathway Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
CXCR1 Inhibitors -Pipeline Insights CXCR1 Inhibitors -Pipeline Insights - Product Thumbnail Image

CXCR1 Inhibitors -Pipeline Insights

“CXCR1 Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Colony Stimulating Factor inhibitor -Pipeline Insights Colony Stimulating Factor inhibitor -Pipeline Insights - Product Thumbnail Image

Colony Stimulating Factor inhibitor -Pipeline Insights

“Colony Stimulating Factor inhibitor-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
5-HT2C Agonists -Pipeline Insights 5-HT2C Agonists -Pipeline Insights - Product Thumbnail Image

5-HT2C Agonists -Pipeline Insights

“5-HT2C Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
5-HT2B Antagonists -Pipeline Insights 5-HT2B Antagonists -Pipeline Insights - Product Thumbnail Image

5-HT2B Antagonists -Pipeline Insights

“5-HT2B Antagonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights - Product Thumbnail Image

TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights

“TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective...

February 2015
FROM
Topoisomerase Inhibitors -Pipeline Insights Topoisomerase Inhibitors -Pipeline Insights - Product Thumbnail Image

Topoisomerase Inhibitors -Pipeline Insights

“Topoisomerase Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights - Product Thumbnail Image

Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights

“Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the...

February 2015
FROM
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights - Product Thumbnail Image

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights

“Peroxisome Proliferator-Activated Receptor (PPAR) Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the...

February 2015
FROM
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights - Product Thumbnail Image

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights

“Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S